Stay updated on KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial

Sign up to get notified when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value on the webpage has changed from 07 to 24, indicating a recent update in medical and healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-05-25T08:42:20.000Z thumbnail image
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating a recent update in the context of medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-05-22T08:11:10.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    18 days ago
    Change Detected
    Summary
    The value 03 25 has been updated to 05 07 on the webpage, indicating a recent change in the study record details related to the safety, tolerability, and efficacy of KPT-8602 in participants with relapsed/refractory cancer indications.
    Difference
    0.7%
    Check dated 2024-05-07T20:17:34.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T23:09:31.000Z thumbnail image

Stay in the know with updates to KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.